Key Considerations for the Lenvatinib-Pembrolizumab-Chemotherapy Regimen in Advanced Gastric Cancer: Insights From LEAP-015

Affiliation

• ¹ Zhengqi Jiang, MD, and Yandong Xiang, MD, Department of Gastrointestinal Surgery, Xiangya Third Hospital, Central South University, Changsha, Hunan, China; and Bo Yi, MD, PhD, Department of Gastrointestinal Surgery, Chongqing University Cancer Hospital, Chongqing, China.